mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |